GuidAge study: A 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. I. Rationale, design and baseline data

Current Alzheimer Research

Volumn 5, Issue 4, 2008, Pages 406-415

  Andrieu, Sandrine ^a,b,c   Ousset, Pierre Jean ^a,b,d   Coley, Nicola ^a,b   Ouzid, Mehemed ^e   Mathiex Fortunet, Hélène ^e   Vellas, Bruno ^a,b,d,f  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d CHU PURPAN   (France)

^e IPSEN   (France)

^f Serv Univ Psychiat l'Enfant l'A   (France)

Author keywords

Alzheimer's disease; Clinical trial; EGb 761; Memory complaints; Secondary prevention

Indexed keywords

GINKGO BILOBA EXTRACT; PLACEBO;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESEARCH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PATIENT SELECTION; PERSONALITY TEST; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIOXIDANTS; DOUBLE-BLIND METHOD; FEMALE; GERIATRICS; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PLANT EXTRACTS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SURVIVAL ANALYSIS;

EID: 48749105650     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720508785132271     Document Type: Article

References (40)

1. World Health Organisation. Neurological disorders: public health challenges. Geneva: World Health Organisation (2007).
2. Hay JW, Yu WM and Ashraf T. Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease. Pharmacoeconomics 15:47-74 (1999).
3. Doraiswamy PM and Xiong GL. Pharmacological strategies for the prevention of Alzheimer's disease. Expert Opin Pharmacother 7: 1-10 (2006).
4. Diamond BJ, Shiflett SC, Feiwel N, Matheis, RJ, Noskin, O, Richards JA, et al. Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil 81: 668-78 (2000).
5. Kanowski S and Hoerr R. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry 36: 297-303 (2003).
6. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM and Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 278: 1327-32 (1997).
7. Schneider LS, DeKosky ST, Farlow MR, Tariot PN, Hoerr R and Kieser M. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. Curr Alzheimer Res 2: 541-51 (2005).
8. Oken BS, Storzbach DM and Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 55: 1409-15 (1998).
9. Birks J, Grimley and Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev: CD003120 (2007).
10. van Dongen M, van Rossum E, Kessels A, Sielhorst H and Knipschild P. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J Clin Epidemiol 56(4): 367-76 (2003).
11. Dodge HH, Zitzelberger T, Oken BS, Howieson D and Kaye J. A randomized placebo-controlled trial of ginkgo biloba for the prevention of cognitive decline. Neurology 70(19 Pt 2): 1809-17 (2008).
12. DeKosky ST, Fitzpatrick A, Ives DG, Saxton J, Williamson J, Lopez OL, et al. The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials 27: 238-53 (2006).
13. Vellas B, Andrieu S, Ousset PJ, Ouzid M and Mathiex-Fortunet H. The GuidAge study: Methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761(R) for prevention of Alzheimer disease in patients over 70 with a memory complaint. Neurology 67: S6-S11 (2006).
14. Lipman T and Covi L. Outpatient treatment of neurotic depression: medication and group psychotherapy. In: Spitzer R, Klein D, editors. Evaluation of the psychological therapies. Baltimore, USA: Johns Hopkins University Press; 181-202 (1976).
15. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17: 37-49 (1982).
16. Folstein MF, Folstein SE and McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-98 (1975).
17. Lechevallier-Michel, N, Fabrigoule, C, Lafont, S, Letenneur, L and Dartigues, JF. [Normative data for the MMSE, the Benton visual retention test, the Isaacs's set test, the digit symbol substitution test and the Zazzo's cancellation task in subjects over the age 70: results from the PAQUID Study]. Rev Neurol (Paris) 160(11): 1059-70 (2004).
18. Grober E, Buschke H, Crystal H, Bang S and Dresner R. Screening for dementia by memory testing. Neurology 38: 900-3 (1988).
19. Berg L. Clinical Dementia Rating. Br J Psychiatry 145: 339 (1984).
20. Hughes CP, Berg L, Danziger WL, Coben LA and Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566-72 (1982).
21. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. Fourth ed. Washington DC, USA: American Psychiatric Association (1994).
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D and Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7): 939-44 (1984).
23. McNair D. and Kahn R. Self-assessment of cognitive deficits, in Assessment in Clinical Psychopharmacology, Crook T, Ferris A and Baltus R, Eds. Mark Powley: New Canaan USA 137-143 (1983).
24. Reitan, R., Validity of the Trail Making Test as an indicator of brain damage. Percept Mot Skills 8: 271-276 (1958).
25. Bechtold, H., A. Benton and M. Fogel, An application of factor analysis in neuropsychology. Psychol Record 12: 147-156 (1962).
26. Cardebat D, Doyon B, Puel M, Goulet P and Joanette Y. Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level]. Acta Neurol Belg 90(4): 207-17 (1990).
27. Lawton, M.P. and E.M. Brody, Assessment of older people: selfmaintaining and instrumental activities of daily living. Gerontologist 9(3): 179-86 (1969).
28. Vellas BJ, Wayne SJ, Romero L, Baumgartner RN, Rubenstein LZ and Garry PJ. One-leg balance is an important predictor of injurious falls in older persons. J Am Geriatr Soc 45(6): 735-8 (1997).
29. Dartigues JF, Fabrigoule C, Letenneur L, Amieva H, Thiessard F and Orgogozo JM. [Epidemiology of memory disorders]. Therapie 52(5): 503-6 (1997).
30. Kawas C, Gray S, Brookmeyer R, Fozard J and Zonderman A. Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 54(11): 2072-7 (2000).
31. Petersen RC, Mild cognitive impairment as a diagnostic entity. J Intern Med 256(3): 183-94 (2004).
32. Bassett SS and Folstein MF. Memory complaint, memory performance, and psychiatric diagnosis: a community study. J Geriatr Psychiatry Neurol 6(2): 105-11 (1993).
33. Derouesne C, Alperovitch A, Arvay N, Migeon P, Moulin F, Vollant M, et al. Memory complaints in the elderly: a study of 367 community-dwelling individuals from 50 to 80 years old. Arch Gerontol Geriatr Suppl 1: 151-63 (1989).
34. Gagnon M, Dartigues JF, Mazaux JM, Dequae L, Letenneur L, Giroire JM, et al. Self-reported memory complaints and memory performance in elderly French community residents: results of the PAQUID Research Program. Neuroepidemiology 13(4): 145-54(1994).
35. Minett TS, Dean JL, Firbank M, English P and O'Brien JT. Subjective memory complaints, white-matter lesions, depressive symptoms, and cognition in elderly patients. Am J Geriatr Psychiatry 13(8): 665-71(2005).
36. Tsai DH, Green RC, Benke KS, Silliman RA and Farrer LA. Predictors of subjective memory complaint in cognitively normal relatives of patients with Alzheimer's disease. J Neuropsychiatry Clin Neurosci 18(3): 384-8(2006).
37. Zandi, T., Relationship between subjective memory complaints, objective memory performance, and depression among older adults. Am J Alzheimers Dis Other Demen 19(6): 353-60(2004).
38. Turvey CL, Schultz S, Arndt S, Wallace RB and Herzog R. Memory complaint in a community sample aged 70 and older. J Am Geriatr Soc 48(11): 1435-41(2000).
39. Adam S, Van Der Linden M and Poitrenaud J. Ĺpreuve de Rappel Indicé à 48 items (RI-48). Ĺvaluation des troubles de la mémoire, in La stimulation cognitive, Michel B, Rotrou J and Verdureau F, Eds. Solal: Marseille, France (2004).
40. Poitrenaud J, Israël L and Barrère H. Elaboration d'une version française abrégée de léchelle de difficultés cognitives de MacNair et Kahn, in La stimulation cognitive, Michel B, Rotrou J and Verdureau F. Editors. Solal: Marseille, France (2004).